Search results for "Elea"

showing 10 items of 772 documents

Trends in infant leukaemia in West Germany in relation to in utero exposure due to Chernobyl accident.

1998

A temporary increase in the incidence of infant leukaemia in Greece was reported by Petridou et al., which was attributed to in utero exposure to ionising radiation resulting from the Chernobyl accident. We performed a similar analysis based on the data of the German Childhood Cancer Registry in order to check whether the observation could be confirmed by means of independent data. Applying the same definitions as Petridou et al., we also observed an increased incidence of infant leukaemia in a cohort of children born after the Chernobyl accident. More detailed analyses, regarding areas with different contamination levels and dose rate gradients over time after the accident, showed, however…

Pediatricsmedicine.medical_specialtyBiophysicsRadiation DosageInfant Newborn DiseasesWest germanyNuclear ReactorsPregnancyEnvironmental healthGermanyRadiation IonizingMedicineHumansIndependent dataRadiation InjuriesGeneral Environmental ScienceLeukemia Radiation-InducedChildhood Cancer RegistryRadiationbusiness.industryIncidence (epidemiology)Infant NewbornInfantIn uteroMaternal ExposureChild PreschoolCohortFemalebusinessDose rateRadioactive Hazard ReleaseUkrainePower PlantsRadiation and environmental biophysics
researchProduct

In vitro release of lectins by Phallusia mamillata hemocytes.

1991

Abstract α-Lactose specific lectins are released from Phallusia mamillata hemocytes during short-term cultures. The molecular weight of the subunits, the immunological cross-reaction and the sugar specificity suggest that the released lectins are similar to those isolated from the sonicated hemocytes. Because lectin release appears to take place independently of active protein synthesis, the possibility exists that lectins are pre-formed, stored in hemocytes and released when in vitro conditions stimulate the cells.

PhallusiaAmanitinsHemocytesHemocyteImmunologyBiologyTunicateLectinsAnimalsUrochordataCycloheximideCells Culturedchemistry.chemical_classificationLectinActive proteinbiology.organism_classificationIn vitroCulture MediaBiochemistrychemistryReleasebiology.proteinDactinomycinLiberationGlycoproteinSecretory RateLectinDevelopmental BiologyDevelopmental and comparative immunology
researchProduct

Functional Magnetic Mesoporous Silica Microparticles Capped with an Azo-Derivative: A Promising Colon Drug Delivery Device

2018

[EN] Magnetic micro-sized mesoporous silica particles were used for the preparation of a gated material able to release an entrapped cargo in the presence of an azo-reducing agent and, to some extent, at acidic pH. The magnetic mesoporous microparticles were loaded with safranin O and the external surface was functionalized with an azo derivative 1 (bearing a carbamate linkage) yielding solid S1. Aqueous suspensions of S1 at pH 7.4 showed negligible safranin O release due to the presence of the bulky azo derivative attached onto the external surface of the inorganic scaffold. However, in the presence of sodium dithionite (azoreductive agent), a remarkable safranin O delivery was observed. A…

Pharmaceutical Science02 engineering and technologyFerric Compounds01 natural sciencesazo reductorcolon releaseAnalytical ChemistrySodium dithionitechemistry.chemical_compoundQUIMICA ORGANICADrug DiscoveryMoietymagnetic mesoporous silicaDrug CarriersAqueous solutionHydrolysisHydrogen-Ion ConcentrationSilicon Dioxide021001 nanoscience & nanotechnologyControlled releaseMicrospheresChemistry (miscellaneous)Drug deliveryMolecular Medicine0210 nano-technologyOxidation-ReductionPorosityColonSurface Properties010402 general chemistryArticleMagneticsChloridesSafraninQUIMICA ANALITICAHumansFerrous CompoundsPhysical and Theoretical Chemistrymagnetic mesoporous silica; azo derivatives; pH triggered; azo reductor; colon releaseQUIMICA INORGANICAOrganic ChemistryDithioniteMesoporous silica0104 chemical sciencesDrug LiberationchemistryNanoparticlesPhenazinespH triggeredMesoporous materialAzo Compoundsazo derivativesNuclear chemistryMolecules; Volume 23; Issue 2; Pages: 375
researchProduct

Propolis-Based Nanofiber Patches to Repair Corneal Microbial Keratitis

2021

In this research, polyvinyl-alcohol (PVA)/gelatin (GEL)/propolis (Ps) biocompatible nanofiber patches were fabricated via electrospinning technique. The controlled release of Propolis, surface wettability behaviors, antimicrobial activities against the S. aureus and P. aeruginosa, and biocompatibility properties with the mesenchymal stem cells (MSCs) were investigated in detail. By adding 0.5, 1, and 3 wt.% GEL into the 13 wt.% PVA, the morphological and mechanical results suggested that 13 wt.% PVA/0.5 wt.% GEL patch can be an ideal matrix for 3 and 5 wt.% propolis addition. Morphological results revealed that the diameters of the electrospun nanofiber patches were increased with GEL (from…

Pharmaceutical ScienceBiocompatible Materials02 engineering and technologyGelatinAnalytical ChemistryContact angleQD241-4410302 clinical medicineAnti-Infective AgentsSpectroscopy Fourier Transform InfraredDrug DiscoveryMesenchymal stem cell proliferationDrug CarriersChemistrySSCAFFOLDHYDROGELP<i>S. aureus</i>021001 nanoscience & nanotechnologyControlled releaseaeruginosaElectrospinningpropolisChemistry (miscellaneous)microbial keratitisPseudomonas aeruginosaBLINDNESSMolecular MedicineELECTROSPUN0210 nano-technologyStaphylococcus aureusfood.ingredient<i>P. aeruginosa</i>BiocompatibilitySurface PropertiesFABRICATIONMicrobial Sensitivity TestsCHEMICAL-COMPOSITIONaureusArticle03 medical and health sciencesfoodnanofibersPhysical and Theoretical Chemistrycorneal patchelectrospinningKeratitisCOMPOSITEGELATINOrganic ChemistryPropolisS. aureusDrug LiberationP. aeruginosaPolyvinyl AlcoholNanofiber030221 ophthalmology & optometryPROPERTYMEMBRANENuclear chemistry
researchProduct

Influence of poloxamers on the dissolution performance and stability of controlled-release formulations containing Precirol® ATO 5

2005

Abstract Lipid excipients are usually used for the development of sustained-release formulations. When used in relatively high quantities, Precirol ® ATO 5 imparts sustained-release properties to solid oral dosage forms, by forming a lipid matrix. To control or adjust the drug release kinetics from such lipid matrix however, one must often resort to complementary ingredients or techniques. This study investigates the influence of poloxamers (Lutrol ® ) included in lipid matrices composed of glyceryl palmitostearate (Precirol ® ATO 5) on their dissolution performance and their stability. The addition of these hydrophilic polymers in the lipid matrix increased the amount of theophylline relea…

Pharmaceutical ScienceExcipientPoloxamerMolding (process)In Vitro TechniquesDosage formDiglyceridesExcipientsDrug StabilityTheophyllinemedicineTechnology PharmaceuticalTheophyllineDissolutionChromatographyCalorimetry Differential ScanningViscosityChemistryWaterPoloxamerControlled releaseKineticsMicroscopy ElectronModels ChemicalSolubilityDelayed-Action PreparationsSwellingmedicine.symptomRheologyPorositymedicine.drugInternational Journal of Pharmaceutics
researchProduct

A methacrylic hyaluronic acid derivative for potential application in oral treatment of celiac disease.

2017

Objective: Aim of this work was the synthesis of a methacrylic hyaluronic acid (HA) derivative and the production, via photocrosslinking, of related hydrogels loaded with an endopeptidase intended for a potential oral treatment of celiac disease. Methods: The methacrylic derivative of HA was prepared through a one-pot procedure involving the reaction with ethylenediamine (EDA) and methacrylic anhydride (MA). The obtained derivative, named HA-EDA-MA, was used to prepare photocrosslinked hydrogels loaded with a prolyl endopeptidase derived from Flavobacterium meningosepticum (PEP FM) able to detoxify gliadin. Obtained hydrogels were recovered as gels or freeze-dried powders. Results: Hydrogel…

Pharmaceutical ScienceMethacrylic anhydrideprolyl endopeptidaseEthylenediamineAdministration OralEthylenediamine02 engineering and technologyMethacrylate010402 general chemistryMethacrylate01 natural sciencescomplex mixtureschemistry.chemical_compoundMiceProlyl endopeptidaseoral enzyme releaseDrug DiscoveryHyaluronic acidmedicineOrganic chemistryAnimalsHumansHyaluronic AcidPharmacologyChemistryAnimalDrug Discovery3003 Pharmaceutical ScienceOrganic ChemistrySerine Endopeptidasestechnology industry and agricultureUV irradiationHydrogels021001 nanoscience & nanotechnologyEthylenediaminesEndopeptidase0104 chemical sciencesSerine EndopeptidaseHydrogelCeliac DiseaseSelf-healing hydrogelsMethacrylates0210 nano-technologyProlyl OligopeptidasesDerivative (chemistry)Nuclear chemistrymedicine.drugHumanDrug development and industrial pharmacy
researchProduct

Pentoxifylline and Oxypurinol: Potential Drugs to Prevent the “Cytokine Release (Storm) Syndrome” Caused by SARS-CoV-2?

2020

Background: COVID-19, caused by SARS-CoV-2, is a potentially lethal, rapidly-expanding pandemic and many efforts are being carried out worldwide to understand and control the disease. COVID-19 patients may display a cytokine release syndrome, which causes severe lung inflammation, leading, in many instances, to death. Objective: This paper is intended to explore the possibilities of controlling the COVID-19-associated hyperinflammation by using licensed drugs with anti-inflammatory effects. Hypothesis: We have previously described that pentoxifylline alone, or in combination with oxypurinol, reduces the systemic inflammation caused by experimentally-induced pancreatitis in rats. Pentoxifyl…

Pharmacology0303 health sciencesbusiness.industryInflammationmedicine.diseaseSystemic inflammationPentoxifyllineProinflammatory cytokine03 medical and health scienceschemistry.chemical_compoundCytokine release syndrome0302 clinical medicinechemistry030220 oncology & carcinogenesisDrug DiscoveryImmunologyMedicineAcute pancreatitisPancreatitismedicine.symptomXanthine oxidasebusiness030304 developmental biologymedicine.drugCurrent Pharmaceutical Design
researchProduct

Antagonism of corticotropin-releasing factor CRF 1 receptors blocks the enhanced response to cocaine after social stress

2018

Numerous studies have shown that social defeat stress induces an increase in the rewarding effects of cocaine. In this study we have investigated the role played by the main hypothalamic stress hormone, corticotropin-releasing factor (CRF), in the effects that repeated social defeat (RSD) induces in the conditioned rewarding effects and locomotor sensitization induced by cocaine. A total of 220 OF1 mice were divided into experimental groups according to the treatment received before each social defeat: saline, 5 or 10 mg/kg of the nonpeptidic corticotropin-releasing factor CRF1 receptor antagonist CP-154,526, or 15 or 30 µg/kg of the peptidic corticotropin-releasing factor CRF2 receptor ant…

PharmacologySocial stressbusiness.industrymedicine.drug_classAntagonistPharmacologyReceptor antagonistConditioned place preference030227 psychiatryCorticotropin-releasing hormone receptor 1Social defeat03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureAnxiogenicmedicinebusiness030217 neurology & neurosurgerySensitizationEuropean Journal of Pharmacology
researchProduct

In vivopredictive release methods for medicated chewing gums

2012

Understanding the performance of a drug product in vivo plays a key role in the development of meaningful in vitro drug release methodology. In case of functional chewing gums, the mode and the mechanism of release and the site of application differ significantly from other conventional solid oral dosage forms and require a special consideration to extract meaningful information from clinical studies. In the current study, suitable drug release methodology was developed to predict the in vivo performance of an investigated chewing gum product. Different parameters of the drug release testing apparatus described in the Ph. Eur. and Pharmeuropa were evaluated. Drug release data indicate that …

Pharmacologybusiness.industryPharmaceutical ScienceGeneral MedicinePharmacologyChewing gumDosage formIVIVCIn vivoDrug releaseDrug productMedicinePharmacology (medical)In vitro in vivobusinessRelease methodsBiopharmaceutics &amp; Drug Disposition
researchProduct

Synthesis of nitric oxide in the dorsal motor nucleus of the vagus mediates the inhibition of gastric acid secretion by central bombesin

1999

1. Central administration of bombesin inhibits gastric acid production independently of the centrally or peripherally-acting stimuli employed. This study evaluates the role and location of the cerebral nitric oxide (NO) implicated in the inhibitory effect of central bombesin on in vivo rat gastric acid secretion, as induced by distension with 15 cm H2O, insulin (0.75 u.i. kg-1 i.p.) TRH (1.2 microg kg-1, i.c.) or pentagastrin (100 microg kg-1, i.p.). 2. The acid-inhibitory effect of i.c. bombesin (40 ng kg-1) was prevented by prior administration of L-NAME (80 microg kg-1) in the dorsal motor nucleus of the vagus (DMN). This dose of L-NAME when administered into the nucleus of the tractus s…

Pharmacologymedicine.medical_specialtySolitary nucleusBombesinThyrotropin-releasing hormoneBiologyPentagastrinchemistry.chemical_compoundEndocrinologyDorsal motor nucleuschemistryHypothalamusInternal medicinemedicineGastric acidS-Nitroso-N-acetylpenicillaminehuman activitieshormones hormone substitutes and hormone antagonistsmedicine.drugBritish Journal of Pharmacology
researchProduct